Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000002

Chief Legal Officer sold 5,760 shares at $19.50 ($112,295)

  • Chief Legal Officer acquired 5,760 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-02 Exercise or conversion : show line 1 in the form 10b5-1 +5,760 $1.86 $10,714 33,844 D
2025-01-02 Sale : show line 2 in the form 10b5-1 −5,760 $19.50 $112,295 28,084 D
Open-market sales · 5,760 sh · avg $19.50 · $112,295

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-02 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −5,760 53,986 D
Loading xslF345X05/wk-form4_1735856926.xml…